We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
LifeMD Inc | NASDAQ:LFMD | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 2.01% | 12.69 | 12.40 | 12.69 | 12.88 | 12.29 | 12.51 | 849,534 | 23:35:30 |
1. Name and Address of Reporting Person * Velge Bertrand | 2. Issuer Name and Ticker or Trading Symbol LifeMD, Inc. [ LFMD ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 217391 (1) | D | ||||||||
Common Stock | 4/15/2020 | P | 294118 | A | $0.17 | 511509 | D | |||
Common Stock | 8/5/2020 | A | 173234 (5) | A | $0 | 684743 | D | |||
Common Stock | 9/22/2020 | P | 96923 | A | $0.65 (3) | 781666 | D | |||
Common Stock | 12/3/2021 | P | 110000 | A | $3.91 (2) | 891666 | I | By Aliunde LLC |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Warrants to Purchase Common Stock | $0.28 | 5/15/2019 | 5/15/2023 | Common Stock | 217391 | 217391 | D | ||||||||
Stock Option (Right to Buy) | $1.15 | 9/30/2019 | A | 2500 (4) | 9/30/2019 | 9/30/2024 | Common Stock | 2500 | $0 | 2500 | D | ||||
Stock Option (Right to Buy) | $1.15 | 12/31/2019 | A | 2500 (4) | 12/31/2019 | 12/31/2024 | Common Stock | 2500 | $0 | 2500 | D | ||||
Stock Option (Right to Buy) | $1.2 | 3/31/2020 | A | 2500 (4) | 3/31/2021 | 3/31/2025 | Common Stock | 2500 | $0 | 2500 | D | ||||
Stock Option (Right to Buy) | $1.5 | 6/30/2020 | A | 2500 (4) | 6/30/2020 | 6/30/2025 | Common Stock | 2500 | $0 | 2500 | D | ||||
Warrants to Purchase Common Stock | $4.65 | 9/22/2020 | A | 100000 | 9/22/2020 | 9/22/2024 | Common Stock | 100000 | $0 | 100000 | D | ||||
Stock Option (Right to Buy) | $7.95 | 9/30/2020 | A | 2500 (4) | 9/30/2020 | 9/30/2025 | Common Stock | 2500 | $0 | 2500 | D | ||||
Stock Option (Right to Buy) | $7 | 12/31/2020 | A | 2500 (4) | 12/31/2020 | 12/31/2025 | Common Stock | 2500 | $0 | 2500 | D | ||||
Stock Option (Right to Buy) | $11.98 | 3/31/2021 | A | 2500 (4) | 3/31/2021 | 3/31/2026 | Common Stock | 2500 | $0 | 2500 | D | ||||
Stock Option (Right to Buy) | $11.56 | 6/30/2020 | A | 2500 (4) | 6/30/2021 | 6/30/2026 | Common Stock | 2500 | $0 | 2500 | D |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Velge Bertrand C/O LIFEMD, INC. 800 THIRD AVE STE 2800 NEW YORK, NY 10022 | X |
Signatures | ||
/s/ Bertrand Velge | 12/7/2021 | |
**Signature of Reporting Person | Date |
1 Year LifeMD Chart |
1 Month LifeMD Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions